Keiko Nakajima
- Hepatology top 0.5%
- Epidemiology top 5%
- Pathology and Forensic Medicine top 2%
- Pulmonary and Respiratory Medicine top 10%
- Surgery top 10%
- Co-authors
- Ann‐Lii ChengYoriko De SanctisJordi BruixJosep M. LlovetGerold MeinhardtJunji FuruseMasatoshi KudoRiccardo Lencioni
- Topics
- Hepatocellular Carcinoma Treatment and Prognosis (24 papers)Lung Cancer Treatments and Mutations (10 papers)Cancer Genomics and Diagnostics (6 papers)
- Partner nations
- JapanUnited StatesFrance
In The Last Decade
Keiko Nakajima
53 papers receiving 1.8k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Hepatology 1.3k
- Epidemiology 599
- Pathology and Forensic Medicine 471
- Pulmonary and Respiratory Medicine 363
- Surgery 327
Countries citing papers authored by Keiko Nakajima
This map shows the geographic impact of Keiko Nakajima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Keiko Nakajima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Keiko Nakajima more than expected).
Fields of papers citing papers by Keiko Nakajima
This network shows the impact of papers produced by Keiko Nakajima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Keiko Nakajima. The network helps show where Keiko Nakajima may publish in the future.
Co-authorship network of co-authors of Keiko Nakajima
This figure shows the co-authorship network connecting the top 25 collaborators of Keiko Nakajima. A scholar is included among the top collaborators of Keiko Nakajima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Keiko Nakajima. Keiko Nakajima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 9 | |
| 3 | 15 | |
| 4 | 16 | |
| 5 | 1 | |
| 6 | 3 | |
| 7 | 264 | |
| 8 | 36 | |
| 9 | 94 | |
| 10 | 1 | |
| 11 | 5 | |
| 12 | 1 | |
| 13 | 108 | |
| 14 | 155 | |
| 15 | 2 | |
| 16 | 8 | |
| 17 | 4 | |
| 18 | 0 | |
| 19 | 37 | |
| 20 | 143 |
About Keiko Nakajima
Keiko Nakajima is a scholar working on Hepatology, Microbiology and Nephrology, having authored 58 papers that have together received 1.9k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (24 papers), Lung Cancer Treatments and Mutations (10 papers) and Cancer Genomics and Diagnostics (6 papers). The work is most often cited by research in Hepatology (1.3k citations), Pathology and Forensic Medicine (471 citations) and Cancer Research (300 citations). Keiko Nakajima has collaborated with scholars based in Japan, United States and France. Frequent co-authors include Ann‐Lii Cheng, Yoriko De Sanctis, Jordi Bruix, Josep M. Llovet, Gerold Meinhardt, Junji Furuse, Masatoshi Kudo, Riccardo Lencioni, Lucy Dagher and Laura Ladrón de Guevara. Their work appears in journals such as Journal of Clinical Oncology, Blood and Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.